Title :

Impact of qrs duration on decision of early removal of pacing catheter after transcatheter aortic valve replacement with corevalve device

Author(s) :

Takahashi, Masao [Auteur]
Mouillet, Gauthier [Auteur]
Deballon, Ronan [Auteur]
Sudre, Arnaud [Auteur]
Lellouche, Nicolas [Auteur]
Lim, Pascal [Auteur]
Modine, Thomas [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 [TCDV]
Van Belle, Eric [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Dubois-Rande, Jean-Luc [Auteur]
Teiger, Emmanuel [Auteur]

Journal title :

The American journal of cardiology

Abbreviated title :

Am. J. Cardiol.

Volume number :

120

Pages :

838-843

Publication date :

2017-09-01

ISSN :

0002-9149

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

The purpose of this study was to determine the predictability of QRS duration (QRSd) for temporary pacing catheter removal in patients implanted with CoreValve. Permanent pacemaker implantation is a known complication after ...
Show more >The purpose of this study was to determine the predictability of QRS duration (QRSd) for temporary pacing catheter removal in patients implanted with CoreValve. Permanent pacemaker implantation is a known complication after transcatheter aortic valve replacement (TAVI) with CoreValve. Although post-TAVI QRSd is highly predictive for advanced atrioventricular block (AVB), management of delayed AVB after TAVI remains unclear. We conducted a multicentric, prospective study of 156 consecutive patients who underwent TAVI with CoreValve between December 2010 and January 2013. Patients who had acute AVB after TAVI were excluded (n = 25). We classified the patients into 2 groups based on the post-TAVI QRSd. Patients with QRSd <120 ms were assigned to early pacing catheter removal group (n = 34), and patients with QRSd ≥120 ms were assigned to keep the pacing catheter with monitoring group (n = 97). No patient required permanent pacemaker implantation in the early pacing catheter removal group, whereas 38 patients with QRSd ≥120 ms had a delayed AVB (QRSd <120 ms vs ≥120 ms: 0% vs 39%, p = 0.0001). The intensive care unit stay length, 30-day mortality, and incidence of complications were lower in the early catheter removal group. Post-TAVI QRSd allows patient selection for early removal of pacing catheter in patients implanted with CoreValve.Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

CHU Lille
CNRS
Inserm
Institut Pasteur de Lille
Université de Lille

Collections :

• Récepteurs nucléaires, Maladies Cardiovasculaires et Diabète (EGID) - U1011

Submission date :

2019-11-27T13:35:54Z